Search

The CMVictory Study aims to learn more about the safety and effectiveness of a potential CMV vaccine.

MenABCWY QUINTET Study Meningococcal disease is a rare but serious disease that can result in death if not recognised and treated quickly. There are

Coming up in 2021 We have a a study to suit every age range in 2021!  From babies at just six weeks for the FluBub Study, through to teenagers in

Latest news & events at the Wesfarmers Centre of Vaccines & Infectious Diseases.

IIC Perth 2019 Faculty Testimonials Contact us I liked the breadth available in the course: both local and international, and very specialised areas

News & Events

More information For more information regarding the Respiratory Symposium, please contact Dr Hannah Moore.

Wesfarmers Centre of Vaccines & Infectious Diseases resources

Research

Emerging evidence indicates that interactions between bacteria shape the nasopharyngeal microbiome and influence respiratory health. This Review uses the systematic scoping methodology to summarise 88 studies including observational and experimental studies, identifying key interactions between bacteria that colonise the human nasopharynx. 

Research

We have read with interest the new publication by Rouhiainen and colleagues on missed opportunities for preventing or diagnosing acute rheumatic fever (ARF).

Research

Edaravone is used to treat motor neurone disease (MND) by slowing disease progression and prolonging survival time. Currently, it is available as an IV infusion (Radicava®, Jersey City, NJ, USA) and an oral liquid suspension (Radicava ORS®, Jersey City, NJ, USA). Development of novel edaravone formulations is still an active field of research that requires a validated stability-indicating assay capable of providing specific, precise, and accurate quantification of edaravone content.